|
Volumn 32, Issue 10, 2010, Pages 777-781
|
[Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CETUXIMAB;
DRUG DERIVATIVE;
IRINOTECAN;
MONOCLONAL ANTIBODY;
OXALIPLATIN;
PLATINUM COMPLEX;
RAS PROTEIN;
ACNE;
ADENOCARCINOMA;
ADULT;
ARTICLE;
CANCER STAGING;
CHEMICALLY INDUCED DISORDER;
COLON TUMOR;
DIARRHEA;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLOW UP;
HUMAN;
LIVER TUMOR;
LUNG TUMOR;
LYMPH NODE METASTASIS;
MALE;
METABOLISM;
METASTASIS;
MIDDLE AGED;
NEUTROPENIA;
PATHOLOGY;
RECTUM TUMOR;
REMISSION;
SURVIVAL RATE;
TUMOR RECURRENCE;
ACNEIFORM ERUPTIONS;
ADENOCARCINOMA;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
COLONIC NEOPLASMS;
DIARRHEA;
DISEASE-FREE SURVIVAL;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LIVER NEOPLASMS;
LUNG NEOPLASMS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
NEUTROPENIA;
ORGANOPLATINUM COMPOUNDS;
RAS PROTEINS;
RECTAL NEOPLASMS;
REMISSION INDUCTION;
SURVIVAL RATE;
|
EID: 84862833309
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|